08 June 2023: Clinical Research
Analysis of Factors Related to Type 2 Diabetic Peripheral Neuropathy Based on Flash Glucose Monitoring System
Qian Ma ABCDEF*DOI: 10.12659/MSM.939157
Med Sci Monit 2023; 29:e939157
Table 1 Comparison of clinical data and biochemical indicators χ̄±s, n/n, M (QL, QU).
| Index | Total (n=325) | DPN group (n=150) | Non-DPN group (n=175) | p |
|---|---|---|---|---|
| Gender (male/female) | 170 (52.3)/155 (47.7) | 80 (53.3)/70 (46.7) | 90 (51.4)/85 (48.6) | 0.732 |
| Age (years) | 59.30±9.85 | 59.89±9.03 | 58.80±10.51 | 0.076 |
| Diabetes course (years) | 7.62±4.90 | 8.75±5.67 | 6.65±3.89 | 0.043 |
| Smoking n (%) | 108 (33.2) | 68 (54.3) | 40 (22.9) | 0.000 |
| BMI (Kg/m) | 26.38±3.50 | 26.43±3.31 | 26.35±3.67 | 0.326 |
| SBP (mmHg) | 136.60±12.82 | 136.57±13.59 | 136.61±12.16 | 0.105 |
| DBP (mmHg) | 77.18±9.73 | 76.95±9.89 | 77.37±9.62 | 0.764 |
| FBG (mmol/L) | 10.67±3.13 | 11.11±3.02 | 10.28±3.18 | 0.036 |
| 2hPG (mmol/L) | 15.96±5.37 | 16.83±5.05 | 15.22±5.54 | 0.041 |
| HbA1c(%) | 9.39±2.55 | 9.84±2.69 | 9.00±2.35 | 0.022 |
| HOMA-IR | 4.40±2.20 | 5.08±2.34 | 3.81±1.90 | 0.038 |
| TC (mmol/L) | 5.21±1.33 | 5.36±1.47 | 5.08±1.19 | 0.523 |
| TG (mmol/L) | 1.54 (1.11–2.38) | 1.45 (1.06–2.20) | 1.63 (1.23–2.44) | 0.143 |
| HDL-C (mmol/L) | 1.33±0.41 | 1.38±0.47 | 1.29±0.36 | 0.146 |
| LDL-C (mmol/L) | 3.23±1.03 | 3.36±1.02 | 3.11±1.03 | 0.283 |
| Diabetes treatment | ||||
| Insulin n (%) | 128 (39.4) | 62 (41.3) | 66 (37.7) | 0.506 |
| Hypoglycemic drugs n (%) | 195 (60) | 86 (57.3) | 109 (62.3) | 0.364 |
| Hypertension n (%) | 199 (61.2) | 95 (63.3) | 104 (59.4) | 0.471 |
| Statins n (%) | 183 (56.3) | 87 (58) | 96 (54.9) | 0.569 |